类脂蛋白沉积症的临床特征与显微喉手术长期疗效
该回顾性队列纳入46例经全身麻醉下喉病变显微手术切除的类脂蛋白沉积症患者,收集临床、遗传及嗓音评估资料。所有患者5岁前出现声嘶,58.7%出生时即有;术后6个月G、VHI-30及MPT显著改善,1年改善率达100%并维持至2年,71.7%恢复声门完全闭合。
要点
- 类脂蛋白沉积症以婴幼儿期持续性声嘶为典型表现,常伴弥漫性双侧声带黄色沉积物。
- 显微喉手术可显著改善喉部形态与嗓音质量,长期疗效稳定。
- 部分患者可行声带脂肪注射作为有效补充治疗。
核心结论
- 类脂蛋白沉积症典型表现为婴幼儿期持续性声嘶,由弥漫性声带沉积物所致。
- 显微喉手术可显著改善喉部形态与嗓音质量,长期疗效稳定。
- 声带脂肪注射可作为部分患者的有效补充治疗。
- 早期识别与手术干预对优化嗓音结局至关重要。
研究设计与样本
- 回顾性队列研究,纳入46例经全身麻醉下喉病变显微手术切除的类脂蛋白沉积症患者。
- 收集临床、遗传及嗓音质量评估资料,包括GRBAS、VHI-30、声学/空气动力学参数及喉镜特征。
- 评估时间点为术前及术后2、6、12、24个月。
主要发现
- 全部46例患者均在5岁前出现声嘶,其中58.7%出生时即表现。
- 喉镜下所有患者均见弥漫性双侧声带黄色沉积物,黏膜波明显减弱。
- 杓状软骨(73.9%)、口腔(63.0%)及咽部(41.3%)受累常见;皮肤表现包括眼睑丘疹(73.9%)和肢体病变(69.6%)。
- 术后6个月G评分(2.70 ± 0.38降至1.48 ± 0.51,p < 0.01)、VHI-30(55.6 ± 21.9降至42.2 ± 20.9,p < 0.05)及MPT(8.3 ± 2.9 s升至9.6 ± 2.4 s,p < 0.05)显著改善。
- 1年时改善率达100%并维持至2年;71.7%患者恢复声门完全闭合,6例接受二次声带脂肪注射后进一步改善。
临床怎么用
- 对婴幼儿期持续性声嘶患者应警惕类脂蛋白沉积症,早期行喉镜检查识别声带沉积物。
- 显微喉手术可作为改善喉部形态与嗓音质量的主要治疗手段,长期疗效稳定。
- 对部分合适患者可考虑声带脂肪注射作为补充治疗以进一步改善嗓音。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To analyze the clinical characteristics of patients with lipoid proteinosis and evaluate the long-term efficacy of microsurgical treatment for laryngeal lesions. METHODS: This retrospective cohort study included 46 patients diagnosed with lipoid proteinosis following microsurgical resection of laryngeal lesions under general anesthesia. Clinical, genetic, and voice quality assessments (GRBAS, VHI-30, acoustic/aerodynamic parameters, laryngoscopic features) were collected preoperatively and at 2, 6, 12, and 24 months postoperatively. RESULTS: All 46 patients developed hoarseness before age 5, with 58.7% presenting at birth. Laryngoscopy revealed diffuse bilateral yellowish vocal fold deposits with markedly reduced mucosal waves in all patients; arytenoid (73.9%), oral (63.0%), and pharyngeal (41.3%) involvement were common. Skin manifestations included eyelid papules (73.9%) and extremity lesions (69.6%). At 6 months postoperatively, significant improvements were observed in G (2.70 ± 0.38-1.48 ± 0.51, p < 0.01), VHI-30 (55.6 ± 21.9-42.2 ± 20.9, p < 0.05), and MPT (8.3 ± 2.9-9.6 ± 2.4 s, p < 0.05). The improvement rate reached 100% at 1 year and remained stable at 2 years. Complete glottic closure was restored in 71.7% of patients; 6 patients underwent secondary vocal fold fat injection with further improvement. CONCLUSIONS: Lipoid proteinosis typically presents with infantile-onset persistent hoarseness due to diffuse vocal fold deposits. Microlaryngosurgery significantly improves laryngeal morphology and vocal quality with stable long-term outcomes. Vocal fold fat injection may serve as an effective supplementary treatment for selected patients. Early recognition and surgical intervention are crucial for optimizing voice outcomes.
引用
- Liu X, Lin Y, Cheng L, et al. Clinical Characteristics of Lipoid Proteinosis and Long-Term Outcomes of Microlaryngosurgery. Laryngoscope. 2026. PMID: 42587374. doi:10.1002/lary.70811
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。